相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Formoterol, a Long-Acting β2 Adrenergic Agonist, Improves Cognitive Function and Promotes Dendritic Complexity in a Mouse Model of Down Syndrome
Van Dang et al.
BIOLOGICAL PSYCHIATRY (2014)
Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome
Andrea Corrales et al.
JOURNAL OF PINEAL RESEARCH (2014)
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome
Sandra Guidi et al.
BRAIN PATHOLOGY (2013)
Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome
D. Colas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn
Elizabeth Kida et al.
EXPERIMENTAL NEUROLOGY (2013)
Rivastigmine transdermal patches in the treatment of dementia in Alzheimer's disease in adults with Down syndrome-pilot study
V. P. Prasher et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2013)
Lithium rescues synaptic plasticity and memory in Down syndrome mice
Andrea Contestabile et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Size Does Not Always Matter: Ts65Dn Down Syndrome Mice Show Cerebellum-Dependent Motor Learning Deficits that Cannot Be Rescued by Postnatal SAG Treatment
Nicolas Gutierrez-Castellanos et al.
JOURNAL OF NEUROSCIENCE (2013)
Reducing GABAA α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome
Carmen Martinez-Cue et al.
JOURNAL OF NEUROSCIENCE (2013)
Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome
Andrea Corrales et al.
JOURNAL OF PINEAL RESEARCH (2013)
Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome
Xavier Altafaj et al.
NEUROBIOLOGY OF DISEASE (2013)
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome
Fiorenza Stagni et al.
PLOS ONE (2013)
Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome
Faycal Guedj et al.
PRENATAL DIAGNOSIS (2013)
Modulating cognitive deficits and tau accumulation in a mouse model of aging Down syndrome through neonatal implantation of neural progenitor cells
Angela L. Rachubinski et al.
EXPERIMENTAL GERONTOLOGY (2012)
Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down Syndrome Ameliorated by GABAB Receptor Antagonists
Alexander M. Kleschevnikov et al.
JOURNAL OF NEUROSCIENCE (2012)
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial
Marisa Hanney et al.
LANCET (2012)
LACK OF BEHAVIORAL AND COGNITIVE EFFECTS OF CHRONIC ETHOSUXIMIDE AND GABAPENTIN TREATMENT IN THE TS65DN MOUSE MODEL OF DOWN SYNDROME
V. Vidal et al.
NEUROSCIENCE (2012)
Effects of Neonatal Neural Progenitor Cell Implantation on Adult Neuroanatomy and Cognition in the Ts65Dn Model of Down Syndrome
Angela L. Rachubinski et al.
PLOS ONE (2012)
Prenatal Treatment Prevents Learning Deficit in Down Syndrome Model
Maddalena Incerti et al.
PLOS ONE (2012)
Adult-Onset Fluoxetine Treatment Does Not Improve Behavioral Impairments and May Have Adverse Effects on the Ts65Dn Mouse Model of Down Syndrome
Markus Heinen et al.
NEURAL PLASTICITY (2012)
Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial
R. Boada et al.
TRANSLATIONAL PSYCHIATRY (2012)
Down Syndrome and Dementia: A Randomized, Controlled Trial of Antioxidant Supplementation
Ira T. Lott et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome
Jason Lockrow et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Neural Stem Cells Reduce Hippocampal Tau and Reelin Accumulation in Aged Ts65Dn Down Syndrome Mice
D. S. Kern et al.
CELL TRANSPLANTATION (2011)
Environmental Enrichment Rescues Postnatal Neurogenesis Defect in the Male and Female Ts65Dn Mouse Model of Down Syndrome
Lina Chakrabarti et al.
DEVELOPMENTAL NEUROSCIENCE (2011)
G-Protein-Associated Signal Transduction Processes Are Restored after Postweaning Environmental Enrichment in Ts65Dn, a Down Syndrome Mouse Model
C. Baamonde et al.
DEVELOPMENTAL NEUROSCIENCE (2011)
α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome
Mototada Shichiri et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Machine Learning Methods Predict Locomotor Response to MK-801 in Mouse Models of Down Syndrome
Cao D. Nguyen et al.
JOURNAL OF NEUROGENETICS (2011)
Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice
J. Braudeau et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn
Laura G. Reinholdt et al.
MAMMALIAN GENOME (2011)
Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome
Arnaud Duchon et al.
MAMMALIAN GENOME (2011)
Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down Syndrome: Activation of pradrenergic receptor by xamoterol as a potential cognitive enhancer
Mehrdad Faizi et al.
NEUROBIOLOGY OF DISEASE (2011)
Donepezil for Treatment of Cognitive Dysfunction in Children With Down Syndrome Aged 10-17
Priya S. Kishnani et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Perinatal Choline Supplementation Improves Cognitive Functioning and Emotion Regulation in the Ts65Dn Mouse Model of Down Syndrome
Jisook Moon et al.
BEHAVIORAL NEUROSCIENCE (2010)
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome
Patrizia Bianchi et al.
JOURNAL OF NEUROSCIENCE (2010)
EFFECTS OF VOLUNTARY PHYSICAL EXERCISE ON ADULT HIPPOCAMPAL NEUROGENESIS AND BEHAVIOR OF Ts65Dn MICE, A MODEL OF DOWN SYNDROME
M. V. Llorens-Martin et al.
NEUROSCIENCE (2010)
Effect of Leucovorin (Folinic Acid) on the Developmental Quotient of Children with Down's Syndrome (Trisomy 21) and Influence of Thyroid Status
Henri Blehaut et al.
PLOS ONE (2010)
Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model
William J. Netzer et al.
PLOS ONE (2010)
Prenatal NAP plus SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-D-aspartic acid and γ-aminobutyric acid receptors
Joy Vink et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
Julien Laffaire et al.
BMC GENOMICS (2009)
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model
Jason Lockrow et al.
EXPERIMENTAL NEUROLOGY (2009)
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model
Yuanxin Chen et al.
NEUROBIOLOGY OF AGING (2009)
Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Faycal Guedj et al.
PLOS ONE (2009)
Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Donna K. Slonim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups
Aki Takahashi et al.
PSYCHOPHARMACOLOGY (2009)
Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome
A. Salehi et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome
Jon Ortiz-Abalia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome
Noemi Rueda et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801
A. Siddiqui et al.
GENES BRAIN AND BEHAVIOR (2008)
Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome
N. Rueda et al.
NEUROSCIENCE LETTERS (2008)
Prevention of Developmental Delays in a Down Syndrome Mouse Model
Laura Toso et al.
OBSTETRICS AND GYNECOLOGY (2008)
Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial
Jill M. Ellis et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test
Alberto C. S. Costa et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Gene expression profiling in the adult Down syndrome brain
H. E. Lockstone et al.
GENOMICS (2007)
Defects in embryonic Neurogenesis and initial synapse formation in the Forebrain of the Ts65Dn mouse model of down syndrome
Lina Chakrabarti et al.
JOURNAL OF NEUROSCIENCE (2007)
Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype-phenotype relationships
Pavel V. Belichenko et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Classification of human chromosome 21 gene-expression variations in down syndrome:: Impact on disease phenotypes
E. Ait Yahya-Graison et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Preliminary study of the safety and efficacy of donepezil hydrochloride in children with down syndrome: A clinical report series
Gail A. Spiridigliozzi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
Safety and efficacy of rivastigmine in adolescents with Down syndrome: A preliminary 20-week, open-label study
James H. Heller et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome
Sarah Clark et al.
EXPERIMENTAL NEUROLOGY (2006)
One-trial associative odor learning in neonatal mice
CM Armstrong et al.
CHEMICAL SENSES (2006)
Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome
C Martínez-Cué et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome
RJ Siarey et al.
NEUROPHARMACOLOGY (2005)
Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome
K Amano et al.
HUMAN MOLECULAR GENETICS (2004)
Minocycline prevents cholinergic loss in a mouse model of Down's syndrome
CL Hunter et al.
ANNALS OF NEUROLOGY (2004)
Global disruption of the cerebellar transcriptome in a Down syndrome mouse model
NG Saran et al.
HUMAN MOLECULAR GENETICS (2003)
Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome:: Effects of environmental enrichment
M Dierssen et al.
CEREBRAL CORTEX (2003)
Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome
AC Granholm et al.
HIPPOCAMPUS (2003)
The effects of piracetam on cognitive performance in a mouse model of Down's syndrome
TH Moran et al.
PHYSIOLOGY & BEHAVIOR (2002)
Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome
ACE Granholm et al.
PHYSIOLOGY & BEHAVIOR (2002)
Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome
C Martínez-Cué et al.
BEHAVIOURAL BRAIN RESEARCH (2002)
Piracetam therapy does not enhance cognitive functioning in children with Down syndrome
NJ Lobaugh et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2001)
Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse
LL Baxter et al.
HUMAN MOLECULAR GENETICS (2000)